JANSSEN GLOBAL
Janssen is a pharmacetical company that manufactures and provides medications to patients.
JANSSEN GLOBAL
Industry:
Health Care Manufacturing Pharmaceutical
Founded:
1953-01-01
Address:
Raritan, New Jersey, United States
Country:
United States
Website Url:
http://www.janssen.com
Total Employee:
10001+
Status:
Active
Contact:
(732) 524-0400
Similar Organizations
HBT Labs
HBT Labs is a pharmaceutical company that manufactures and supplies complex drugs based on advanced technology for patients.
Nihon Generic
Nihon Generic is a pharmaceutical company that manufactures generic medicinal products.
RxChange
RxChange is a pharmaceutical company that offers physician and point-of-care dispensing services to its patients.
SynQuest, Inc.
SynQuest, Inc. is a company that manufactured treprostinil, the bulk active ingredient in Remodulin.
Tyche Industries
Tyche is a pharmaceutical company that manufactures APIs & Advanced Intermediates of APIโs.
Current Employees Featured
Official Site Inspections
http://www.janssen.com
- Host name: 172.64.145.46
- IP address: 172.64.145.46
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Janssen Global"
Company | Janssen
3 days ago Janssen partners directly with patients and caregivers as we develop medicines, improve clinical trials, and create educational materials and support programs. See More > โฆSee details»
Janssen Pharmaceuticals - Wikipedia
The early roots of what would become Janssen Pharmaceuticals date back to 1933. In 1933, Constant Janssen, the father of Paul Janssen, acquired the right to distribute the pharmaceutical products of Richter, a Hungarian pharmaceutical company, for Belgium, the Netherlands and Belgian Congo. On 23 October 1934, he founded the N.V. Produkten Richter in Turnhout. In 1937, Constant JโฆSee details»
About Janssen Global - Janssen United States
May 5, 2015 This information is intended for use by our customers, patients, and healthcare professionals in the United States only. Janssen Pharmaceuticals, Inc., recognizes that the โฆSee details»
Meet our leadership team - Janssen
Sep 26, 2024 Federico Feldstein is the Vice President and Chief Quality Officer of Innovative Medicine at Johnson & Johnson. In his current role, Federico leads the Innovative Medicine โฆSee details»
About us - Janssen
Inspired by patients, and the legacy of industry pioneer Dr. Paul Janssen, we continue with the vision of developing science-based innovations to change and save lives. Who we are Who โฆSee details»
About Janssen - bioadvance.ca
About Janssen. Janssen Inc. is driven by our passionate pursuit of science.We invest in our own research and development efforts while we work to bring innovative ideas, products and โฆSee details»
Welcome to Janssen Scienceโข
Dec 18, 2024 Contact Janssen Scienceโข for your Medical Inquiries Chat live For selected products; Search Medical information; Connect with My medical science liaison; Call me now; โฆSee details»
The Janssen Pharmaceutical Companies of Johnson & Johnson
At Janssen, we never stop working toward a future where disease is a thing of the past. Weโre the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep โฆSee details»
Janssen - Crunchbase Investor Profile & Investments
At Janssen, the pharmaceutical companies of Johnson & Johnson, our mission is to transform individual lives and change fundamentally the way diseases are managed, interpreted, and โฆSee details»
Janssen Announces New Group Targeting Unmet Global Health โฆ
Jan 22, 2014 In September 2013, Janssen entered into a licensing agreement with PATH, an international non-profit organization that transforms global health through innovation, for the โฆSee details»
Janssen Vaccines - Wikipedia
Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical technologies. It was formed when Johnson & Johnson acquired the Dutch โฆSee details»
Janssen Pharmaceuticals - Crunchbase Company Profile & Funding
Janssen Pharmaceuticals reduces the risk of stroke and blood clots in adults and has a medical condition called atrial fibrillation. That is caused by a heart valve problem. The atrial fibrillation, โฆSee details»
We are here to transform the future of health - Janssen United โฆ
Sep 26, 2024 This information is intended for use by our customers, patients, and healthcare professionals in the United States only. Janssen Pharmaceuticals, Inc., recognizes that the โฆSee details»
Janssen | 2022 Transparency Report
Janssen offers a more detailed look at the price reductions it offer payers and others in the healthcare system to support access to its medicines. ... (JJPAF), an independent, nonprofit โฆSee details»
Janssen Company Profile | Management and Employees List
Janssen PMP is a long-established world leader in the development and formulation of new and highly effective active substances and end-use products for the protection of materials and โฆSee details»
Tom Cavanaugh - Company Group Chairman, Johnson & Johnson โฆ
As a result, Janssen Oncology became the industryโs fastest-growing multibillion-dollar oncology business. Before joining Johnson & Johnson, Tom helped build Celgene into a global โฆSee details»
What is Janssen? Company Culture, Mission, Values - Glassdoor
Janssen Pharmaceuticals jaunts across the drug market, offering therapeutics for mental health, neurology, pain management, infectious disease, and a number of other ailments. A US-based โฆSee details»
Our heritage - innovativemedicine.jnj.com
The Janssen name comes from Dr. Paul Janssen, who founded Janssen Pharmaceutica N.V. in 1953. The name embodies our commitment to finding solutions for patients by advancing โฆSee details»
THE 2020 JANSSEN U.S. TRANSPARENCY REPORT
Average net price decline Medicareof Janssen medicines in 202012 $29.4B Total amount Janssen paid in rebates, discounts and fees to payers and others in the health system in โฆSee details»
Nipocalimab granted U.S. FDA Priority Review for the treatment of ...
1 day ago Janssen Research & Development, LLC and Janssen Biotech, Inc. are Johnson & Johnson companies. Cautions Concerning Forward-Looking Statements This press release โฆSee details»